A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol

Iben Kümler, Eva Balslev, Jan Stenvang, Nils Brünner, Dorte Nielsen

    7 Citations (Scopus)
    348 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocol'. Together they form a unique fingerprint.

    Medicine & Life Sciences